Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07556159 · ClinicalTrials.gov registry record

A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice

A clinical trial, sponsored by Sanofi.

Recruiting
Registry status
2,500
Enrollment target

NCT07556159 is a clinical trial that is actively recruiting participants, run by Sanofi. The registered enrollment target is 2,500 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07556159 is actively recruiting participants, sponsored by Sanofi.

RECRUITING
Registry status
2,500 participants
Enrollment target

Study Summary

The main aim of the study to describe the characteristics of participants with asthma across the spectrum of disease severity, including sociodemographic and clinical characteristics, treatment and disease burden, biomarkers, and both disease-specific and generic health-related quality of life. The study consists of two parts: a cross-sectional study, and a prospective follow-up evaluate changes in disease trajectories in participants with asthma.

Interventions

  • OTHER Procedure: Investigational Procedures

Trial Details

FieldValue
Enrollment Target 2,500 participants
Start Date 2026-04-01
Est. Completion 2029-04-04

Sponsor

Sanofi

713 total trials

What the Registry Record Tells You About NCT07556159

The ClinicalTrials.gov registry entry for NCT07556159 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 2,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Procedure: Investigational Procedures is the first listed.

NCT07556159 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07556159 about?

NCT07556159 is a clinical study titled "A Study Evaluating Disease Characteristics and Outcomes in Participants With Asthma in Routine Clinical Practice". The main aim of the study to describe the characteristics of participants with asthma across the spectrum of disease severity, including sociodemographic and clinical characteristics, treatment and disease burden, biomarkers, and both disease-specific and generic health-related quality of life. The...

What is the current status of trial NCT07556159?

This trial is currently recruiting. The enrollment target is 2,500 participants. The study started on 2026-04-01. Estimated completion is 2029-04-04.

What interventions are being tested in trial NCT07556159?

The interventions under investigation include: Procedure: Investigational Procedures (OTHER).

Who is sponsoring clinical trial NCT07556159?

This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.